Message Font: Serif | Sans-Serif
No. of Recommendations: 0
Alright, I've put in my order for a bunch of shares of ZEN on the news of the breast cancer prevention study. The stock closed Friday at 137 and change, shooting up 4 and some on news of merger with Glaxo Wellcome. This breakthrough in the NCI study will probably have ZEN opening around 140, I suspect. The company looks strong, with P/E at 35-ish.

Anyone have any thoughts?
Print the post  


When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.